|

Financial Toxicity in Patients With Early-stage Breast Cancer

RECRUITINGSponsored by National Cancer Institute, Naples
Actively Recruiting
SponsorNational Cancer Institute, Naples
Started2025-09-30
Est. completion2030-09
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07354165

Summary

Non-profit, multicenter, prospective, observational study. This study aims to evaluate whether the articulated treatment algorithm that is now possible for early-stage breast cancer patients does produce tangible changes of financial distress over the time and whether the determinants of financial distress change their relative weight over the time.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Signed informed consent form
* Age \> 18 years at the time of study entry
* Histologically confirmed stage I-III invasive breast carcinoma before starting any systemic treatment.

Exclusion Criteria:

* Stage IV invasive breast carcinoma
* Major cognitive dysfunction or psychiatric disorders
* Any previous systemic treatment for the current breast cancer

Conditions2

Breast CancerCancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.